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Introduction
The majority of cancer cells present an altered energetic
metabolism resorting to aerobic glycolysis, even under aerobic
conditions (“Warburg” effect) and this can be the basis for the
development of new and more effective antitumor agents. 3-
bromopyruvate (3-BP) is an alkylating agent putatively
transported by the monocarboxylate transporters (MCTs), which
targets cancer cell metabolism, and it has been demonstrated to
be a powerful and specific antitumor agent either in in vitro or in
vivo models. 3-BP inhibits tumor energetic metabolism, causing
depletion of intracellular ATP, thus acting as a cytotoxic agent.
Our published results and preliminary transport assays show that
MCT1/4 and CD147 might play a key role in 3-BP uptake.
We investigated the effect of 3-BP in glioblastomas, a very
aggressive cancer, and in colorectal cancer cell lines, which
appears in top three ranking of the most frequent cancer types
[1]. 3-BP cytotoxic effect was assessed at different extracellular
pH (pHe) values and correlated with MCTs expression [2, 3]. 3-BP
effect on migratory capacity and cell metabolism in the different
cell lines was also determined.
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Methods
Sulforhodamine B: The cytotoxic effect of 3-BP in glioblastoma
and colorectal cancer cell lines was evaluated at basal conditions
and at different extracellular pHs. The different cell lines were
exposed in the assayed conditions to 3-BP for 16 hour and cell
viability was determined after this period of time.
Wound healing assay: Cells were plated in 6-well plates and
grown until total confluence. Two wounds were then created in
the confluent cells by manual scratching. Cells were treated with
½ IC50 and IC50 values of the 3-BP, being untreated cells used as
control. Photograph records were obtained cells at 0, 12 and 24
hour. Percentage of cell migration relative to time zero of the
control was evaluated with the GraphPad Prism 5 software.
Glucose and lactate quantification: The different cell lines were
exposed at ½ IC50 and IC50 values of 3-BP and lactate and glucose
were measured in extracellular medium. As control, untreated
cells were used. The obtained results were normalized to the
protein biomass using SRB assay.
Western Blot: Protein extracts of different cancer cell lines were
used to evaluate the MCT1 and MCT4 expression by Western-
blotting. α-tubulin was used as loading control and the density of
each band was determined with the software Image J (version
1.48, NIH).
Final Remarks
•3-BP presented cytotoxic effect to both glioblastoma and
colorectal cancer cell lines, but with different sensitivities.
•3-BP was more cytotoxic at lower pHe in most cell lines assayed,
according to its probable mechanism of transport by a proton-
symport.
•The migratory capacity as well as energetic metabolism were
inhibited by 3-BP, being this effect more evident when higher
concentrations of the compound were used.
• In glioblastomas, MCT4 was more expressed in the most
sensitive cell line, which also present a considerable expression
of MCT1. As 3-BP is transported by MCTs, its cytotoxic effect
probably be associated to the MCTs expression. However, in
colorectal cancer cell lines no direct association was found.
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Table 1. IC50 (µM) values for different cancer cell lines exposed to 3-BP.
Figure 1. Quantification of the extracellular glucose and lactate in different cancer cell lines. Significantly different between groups: *p < 0.05; **p <
0.01; ***p < 0.001; ****p < 0.0001; ns: no statistically significant compared to control.
• 3-BP treatment induced a decrease of glucose consumption and lactate 
production in all cell lines.
• In glioblastoma cell lines, MCT4 is more expressed in 
the most sensitive cell line, U373MG. MCT1 is more 
expressed in U251MG and U373MG cell lines. 
• In colorectal, there was no relevant differences 
between cell lines in MCTs expression.
Table 3. Expression of MCT1 and MCT4 in different cancer cell lines.
Cytotoxic effect of the 3-BP in glioblastoma and colorectal cancer cell lines
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• The cell lines more resistant to 3-BP were U251MG and HT-29, in glioblastoma and colorectal 
cancer cell lines, respectively.
• 3-BP was more cytotoxic at pHe 6.6 than pHe 7.4. It was not possible determinate IC50 value at 
different pHe for Caco-2 and HT-29 in colorectal cancer cell lines.
• This effect was more evident when
higher concentrations of the compound
were used, namely after 24 hours of
treatment.
• 3-BP inhibits migratory capacity of both























































































































































































































































































































































Figure 4. Effect of 3-BP in migration capacity in different cancer cell lines. Significantly
different between groups: *P < 0.1;**P < 0.01; ***P < 0.001; ****P < 0.0001; ns: no
















































































































Figure 5. Expression profile of MCT1 and MCT4 in different cancer cell lines.
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